Xponance LLC Increases Stock Position in UnitedHealth Group Incorporated $UNH

Xponance LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 147,949 shares of the healthcare conglomerate’s stock after buying an additional 9,293 shares during the quarter. Xponance LLC’s holdings in UnitedHealth Group were worth $48,839,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group in the fourth quarter valued at $25,000. Beacon Financial Strategies CORP acquired a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Anfield Capital Management LLC increased its stake in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the fourth quarter valued at $27,000. Finally, Foster Dykema Cabot & Partners LLC increased its stake in UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 34 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.5%

Shares of UNH opened at $405.58 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The firm’s 50-day moving average is $359.59 and its two-hundred day moving average is $326.28. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $415.98. The firm has a market capitalization of $368.32 billion, a P/E ratio of 30.63, a PEG ratio of 1.64 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period in the prior year, the business posted $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be given a $2.32 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 66.77%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a research note on Tuesday, April 7th. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target on the stock in a research note on Wednesday, April 22nd. Oppenheimer boosted their price target on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. TD Cowen boosted their price target on shares of UnitedHealth Group from $311.00 to $337.00 and gave the stock a “hold” rating in a research note on Thursday, April 23rd. Finally, JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $407.17.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth announced it will release second-quarter 2026 results on July 16 and host an investor call the same morning, keeping attention on the company’s upcoming fundamentals and guidance. UnitedHealth Group Announces Earnings Release Date
• Positive Sentiment: UnitedHealth was highlighted as a momentum stock and a “best longevity stock” pick, reflecting improving market sentiment and renewed interest from growth-oriented investors. UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?
• Positive Sentiment: Analysts remain constructive, with Erste Group lifting its FY2027 EPS estimate for UNH and maintaining a Buy rating, reinforcing expectations for earnings recovery. MarketBeat analyst update
• Positive Sentiment: The company also announced a dividend hike, adding to the case that management is confident in cash flow and long-term earnings stability. 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions
• Neutral Sentiment: Coverage focused on whether UNH’s rebound from a weak 2025 has further room to run after touching a 52-week high; this supports the bullish narrative but is more commentary than a new catalyst. UnitedHealth Group Just Hit a 52-Week High. Is It Too Late to Buy This Soaring Stock?

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.